BUDGET IMPACT ANALYSIS OF LINEZOLID IN THE TREATMENT OF COMPLICATED SKIN AND SOFT TISSUE INFECTIONS IN COLOMBIA

被引：0
|
作者：
Diaz-Sotelo, O. D. [1 ]
Barbosa Castro, T. [2 ]
Ortiz, Vecino A. [3 ]
Vargas Zea, N. [4 ]
Quevedo, Mould J. F. [5 ]
Prieto Martinez, V [4 ,6 ]
机构：
[1] RANDOM Fdn, Bogota, DC, Colombia
[2] RANDOM Fdn, Bogota, Colombia
[3] Johns Hopkins Univ, Baltimore, MD USA
[4] Pfizer SAS, Bogota, Colombia
[5] Pfizer Inc, New York, NY USA
[6] Pfizer Inc, Bogota, Colombia
来源：
VALUE IN HEALTH | 2013年 / 16卷 / 03期
关键词：
D O I：
10.1016/j.jval.2013.03.386
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A84 / A84
页数：1
相关论文
共 50 条
  • [31] Randomized comparison of linezolid (PNU-100766) versus oxacillin-dicloxacillin for treatment of complicated skin and soft tissue infections
    Stevens, DL
    Smith, LG
    Bruss, JB
    McConnell-Martin, MA
    Duvall, SE
    Todd, WM
    Hafkin, B
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (12) : 3408 - 3413
  • [32] Impact of linezolid on economic outcomes and determinants of cost in a clinical trial evaluating patients with MRSA complicated skin and soft-tissue infections
    McKinnon, Peggy S.
    Sorensen, Sonja V.
    Liu, Larry Z.
    Itani, Karnal M. F.
    ANNALS OF PHARMACOTHERAPY, 2006, 40 (06) : 1017 - 1023
  • [33] What is the place of linezolid in the treatment of methicillin-resistant Staphylococcus aureus nosocomial pneumonia and complicated skin and soft tissue infections in Europe?
    Dumitrescu, O.
    Lina, G.
    CLINICAL MICROBIOLOGY AND INFECTION, 2014, 20 : 1 - 2
  • [34] Dalbavancin for the Treatment of Complicated Gram-Positive Skin and Soft Tissue Infections
    Petrakis, Vasilios
    Panagopoulos, Periklis
    Papanas, Nikolaos
    INTERNATIONAL JOURNAL OF LOWER EXTREMITY WOUNDS, 2020, 19 (03): : 236 - 241
  • [35] Clinical efficacy of piperacillin/tazobactam in the treatment of complicated skin and soft tissue infections
    Takimoto, Kohei
    Wang, Qianzhi
    Suzuki, Daisuke
    Katayama, Mitsuya
    Hayashi, Yoshiro
    EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (10) : 1027 - 1034
  • [36] Clinical metagenomics for complicated skin and soft tissue infections
    Yang, Wan-Ting
    Lai, Chih-Sheng
    Lai, Kuo-Lung
    Mao, Yan-Chiao
    Liu, Po-Yu
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2021, 58 : 34 - 35
  • [37] Recent Study data on systemic Treatment of complicated Skin and Soft tissue infections
    Quist, S. R.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2011, 9 : 104 - 105
  • [38] COMPLICATED SKIN AND SOFT TISSUE INFECTIONS (CSSTI) FOR INPATIENT AND OUTPATIENT TREATMENT SETTINGS
    Stephens, J. M.
    Treur, M. J.
    Heeg, B. M. S.
    Haider, S.
    Nathwani, D.
    Tice, A.
    VALUE IN HEALTH, 2008, 11 (06) : A441 - A441
  • [39] Comparative effectiveness of antibiotics for the treatment of MRSA complicated skin and soft tissue infections
    Logman, J. Floris S.
    Stephens, Jennifer
    Heeg, Bart
    Haider, Seema
    Cappelleri, Joseph
    Nathwani, Dilip
    Tice, Alan
    van Hout, Ben A.
    CURRENT MEDICAL RESEARCH AND OPINION, 2010, 26 (07) : 1565 - 1578
  • [40] Complicated and deep bacterial skin and soft tissue infections
    Prodinger, Christine
    Lechner, Arno
    Hintersteininger, Arno
    Kern, Jan Marco
    Meissnitzer, Matthias
    Meyersburg, Damian
    Bauer, Johann W.
    Laimer, Martin
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2025, 23 (03): : 357 - 376
12345